Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
February 2025
in “
Journal of Neonatal Surgery
”
New to Metformin? There is a guide in the encyclopedia. Read the guide → 
Studysummary This study explores the role of antidiabetic medications, particularly metformin, GLP-1 receptor agonists, and DPP-4 inhibitors, in managing PCOS, highlighting their combination with hormonal therapies and lifestyle interventions for a comprehensive treatment approach.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This article discusses the management of polycystic ovarian syndrome (PCOS) using antidiabetic drugs, emphasizing the role of insulin sensitizers like metformin, GLP-1 receptor agonists, and DPP-4 inhibitors. These medications, when combined with hormonal therapies such as oral contraceptives, address both insulin resistance and hyperandrogenism. The article also underscores the importance of lifestyle interventions, including diet and exercise, as essential complements to pharmacotherapy. It calls for personalized treatment strategies and further research to enhance combination therapies for better long-term outcomes, highlighting a comprehensive approach to improving metabolic and reproductive health in women with PCOS.
